AAAAAA

   
Results: 1-9 |
Results: 9
Pharmacodynamic and receptor binding changes during chronic lorazepam administration
Authors: Fahey, JM Pritchard, GA Grassi, JM Pratt, JS Shader, RI Greenblatt, DJ
Citation: Jm. Fahey et al., Pharmacodynamic and receptor binding changes during chronic lorazepam administration, PHARM BIO B, 69(1-2), 2001, pp. 1-8
Hybrid organic-inorganic particle technology: Breaking through traditionalbarriers of HPLC separations
Authors: Cheng, YF Walter, TH Lu, ZL Iraneta, P Alden, BA Gendreau, C Neue, UD Grassi, JM Carmody, JL O'Gara, JE Fisk, RP
Citation: Yf. Cheng et al., Hybrid organic-inorganic particle technology: Breaking through traditionalbarriers of HPLC separations, LC GC N AM, 18(11), 2000, pp. 1162
Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions
Authors: von Moltke, LL Greenblatt, DJ Granda, BW Grassi, JM Schmider, J Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions, PSYCHOPHAR, 145(1), 1999, pp. 113-122
Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations
Authors: von Moltke, LL Greenblatt, DJ Granda, BW Duan, SX Grassi, JM Venkatakrishnan, K Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations, BR J CL PH, 48(1), 1999, pp. 89-97
In situ hybridization histochemistry as a method to assess GABA(A) receptor subunit mRNA expression following chronic alprazolam administration
Authors: Fahey, JM Pritchard, GA Grassi, JM Pratt, JS Shader, RI Greenblatt, DJ
Citation: Jm. Fahey et al., In situ hybridization histochemistry as a method to assess GABA(A) receptor subunit mRNA expression following chronic alprazolam administration, J PSYCHOPH, 13(3), 1999, pp. 211-218
Use of high-performance LC packings from pH 1 to pH 12
Authors: Neue, UD Walter, TH Alden, BA Jiang, ZP Fisk, RP Cook, JT Glose, KH Carmody, JL Grassi, JM Cheng, YF Lu, ZL Crowley, RJ
Citation: Ud. Neue et al., Use of high-performance LC packings from pH 1 to pH 12, AM LABORAT, 31(22), 1999, pp. 36
Citalopram and desmethylcitalopram in vitro: Human cytochromes mediating transformation, and cytochrome inhibitory effects
Authors: von Moltke, LL Greenblatt, DJ Grassi, JM Granda, BW Venkatakrishnan, K Duan, SX Fogelman, SM Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Citalopram and desmethylcitalopram in vitro: Human cytochromes mediating transformation, and cytochrome inhibitory effects, BIOL PSYCHI, 46(6), 1999, pp. 839-849
Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects
Authors: von Moltke, LL Greenblatt, DJ Grassi, JM Granda, BW Fogelman, SM Harmatz, JS Kramer, SJ Fabre, LF Shader, RI
Citation: Ll. Von Moltke et al., Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects, PSYCHOPHAR, 140(3), 1998, pp. 293-299
Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3A
Authors: Von Moltke, LL Greenblatt, DJ Grassi, JM Granda, BW Venkatakrishnan, K Schmider, J Harmatz, JS Shader, RI
Citation: Ll. Von Moltke et al., Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3A, J PHARM PHA, 50(9), 1998, pp. 997-1004
Risultati: 1-9 |